Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03550105 · ClinicalTrials.gov registry record · NA
Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and Endurance
A NA study, sponsored by Sackner Wellness Products.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03550105 is a NA study that has completed, run by Sackner Wellness Products. The registered enrollment target is 24 participants.
The verdict
NCT03550105, a NA study, has completed, sponsored by Sackner Wellness Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Physical Inactivity and excessive sedentary behavior are risk factors for diabetes and cardiovascular disease. Movement is important for overall health. This study will assess the validity and usefulness of low risk, non-invasive wellness device, the Gentle Jogger® (GJ) that passively simulates the physical activities of jogging. The study will evaluate whether or not use of GJ modifies glycemic control and muscle strength in subjects who are known to be diabetic and those who are not. The study volunteers are subjects between the ages of 25-80yr.
Interventions
- DEVICE Gentle Jogger
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-06-05 |
| Est. Completion | 2020-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03550105
The ClinicalTrials.gov registry entry for NCT03550105 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sackner Wellness Products, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gentle Jogger is the first listed.
NCT03550105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03550105 about?
NCT03550105 is a clinical study titled "Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and Endurance". Physical Inactivity and excessive sedentary behavior are risk factors for diabetes and cardiovascular disease. Movement is important for overall health. This study will assess the validity and usefulness of low risk, non-invasive wellness device, the Gentle Jogger® (GJ) that passively simulates the ...
What is the current status of trial NCT03550105?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-06-05. Estimated completion is 2020-01-23.
What interventions are being tested in trial NCT03550105?
The interventions under investigation include: Gentle Jogger (DEVICE).
Who is sponsoring clinical trial NCT03550105?
This trial is sponsored by Sackner Wellness Products, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.